Blocking group-directed diastereoselective total synthesis of (±)-α-noscapine

Tetrahedron

Volumn 67, Issue 29, 2011, Pages 5162-5167

  Ni, Jizhi ^a   Xiao, Heping ^a   Weng, Lipeng ^a   Wei, Xiaofeng ^a   Xu, Youjun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Blocking group; Diastereoselective synthesis; Noscapine; Phthalide 3 carboxylic acid; Total synthesis

Indexed keywords

ALPHA NOSCAPINE; BENZOIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; GLYOXYLIC ACID; NOSCAPINE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BISCHLER NAPIERALSKI REACTION; CYCLIZATION; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ONE POT SYNTHESIS; PRIORITY JOURNAL; REACTION OPTIMIZATION; REDUCTION; STEREOCHEMISTRY;

EID: 79958773374     PISSN: 00404020     EISSN: 14645416     Source Type: Journal    
DOI: 10.1016/j.tet.2011.05.060     Document Type: Article

References (38)

1. Robiquet, P. J. Ann. Chim. Phys. 1817, 5, 275-278.
2. (a) Empey, D.W.; Laitinen, L. A.; Young, G. A.; Bye, C. E.; Hughes, D. T. Eur. J. Clin. Pharmacol. 1979, 16, 393-397;
3. (b) Dahlström, B.; Mellstrand, T.; Löfdahl, C.-G.; Johansson, M. Eur. J. Clin. Pharmacol. 1982, 22, 535-539;
4. (c) Karlsson, M. O.; Dahlström, B.; Eckernäs, S.-Å.; Johansson, M.; Tufvesson Alm, A. Eur. J. Clin. Pharmacol. 1990, 39, 275-279.
5. (a) Zhou, J.; Gupta, K.; Yao, J.; Ye, K.; Panda, D.; Giannakakou, P.; Joshi, H. C. J. Biol. Chem. 2002, 277, 39777-39785;
6. (b) Ke, Y.; Ye, K.; Grossniklaus, H. E.; Archer, D. R.; Joshi, H. C.; Kapp, J. A. Cancer Immunol. Immunother. 2000, 49, 217-225;
7. (c) Landen, J. W.; Lang, R.; McMahon, S. J.; Rusan, N. M.; Yvon, A.-M.; Adams, A. W.; Sorcinelli, M. D.; Campbell, R.; Bonaccorsi, P.; Ansel, J. C.; Archer, D. R.; Wadsworth, P.; Armstrong, C. A.; Joshi, H. C. Cancer Res. 2002, 62, 4109-4114;
8. (d) Landen, J. W.; Hau, V.; Wang, M.; Davis, T.; Ciliax, B.; Wainer, B. H.; Van Meir, E. G.; Glass, J. D.; Joshi, H. C.; Archer, D. R. Clin. Cancer Res. 2004, 10, 5187-5201;
9. (e) Mahmoudian, M.; Mehrpour, M.; Benaissa, F.; Siadatpour, Z. Eur. J. Clin. Pharmacol. 2003, 59, 579-581;
10. (f) Khodarahmi, P.; Rostami, P.; Rashidi, A.; Khodarahmi, I. Pharmacol. Rep. 2006, 58, 568-570.
11. For the total synthesis of b-noscapine, see: (a) Hope, E.; Robinson, R. J. Chem. Soc., Trans. 1914, 105, 2085-2104;
12. (b) Marshall, M. A.; Pyman, F. L.; Robinson, R. J. Chem. Soc. 1934, 1315-1320;
13. (c) Lee, D. U. Bull. Korean Chem. Soc. 2002, 23, 1548-1552 See also Ref. 7 and 8.
14. Bognár, R.; Gaál, G. D.; Kerekes, P.; Szabó, S. Pharmazie 1967, 22, 452-454.
15. Perkin, W. H., Jr.; Robinson, R. J. Chem. Soc., Trans. 1911, 99, 775-792.
16. Shono, T.; Hamaguchi, H.; Sasaki, M.; Fujita, S.; Nagami, K. J. Org. Chem. 1983, 48, 1621-1628.
17. Kerekes, V. P.; Bognár, R. J. Prakt. Chem. 1971, 313, 923-928.
18. Varga, Z.; Blaskó, G.; Dörnyei, G.; Szäntay, C. Acta Chim. Hung. 1991, 128, 831-837.
19. For the preparation of halogenated noscapine derivatives from natural noscapine, see: (a) Aneja, R.; Vangapandu, S. N.; Joshi, H. C. Bioorg. Med. Chem. 2006, 14, 8352-8358;
20. (b) Verma, A. K.; Bansal, S.; Singh, J.; Tiwari, R. K.; Sankar, V. K.; Tandon, V.; Chandra, R. Bioorg. Med. Chem. 2006, 14, 6733-6736;
21. (c) Aneja, R.; Vangapandu, S. N.; Lopus, M.; Viswesarappa, V. G.; Dhiman, N.; Verma, A.; Chandra, R.; Panda, D.; Joshi, H. C. Biochem. Pharmacol. 2006, 72, 415-426.
22. (a) Beck, J. J.; Chou, S.-C. J. Nat. Prod. 2007, 70, 891-900;
23. (b) Bentley, R. Chem. Rev. 2000, 100, 3801-3825.
24. (a) Blaskó, G.; Gula, D. J.; Shamma, M. J. Nat. Prod. 1982, 45, 105-122;
25. (b) Bentley, K.W. Nat. Prod. Rep. 2000, 17, 247-268;
26. (c) Bentley, K.W. Nat. Prod. Rep. 1990, 7, 245-268;
27. (d) Soriano, M. D. P. C.; Shankaraiah, N.; Santos, L. S. Tetrahedron Lett. 2010, 51, 1770-1773.
28. For selected examples, see: (a) Russell, R. A.; Pilley, B. A.; Warrener, R. N. Synth. Commun. 1986, 16, 425-430;
29. (b) De Silva, S. O.; Reed, J. N.; Billedeau, R. J.; Wang, X.; Norris, D. J.; Snieckus, V. Tetrahedron 1992, 48, 4863-4878;
30. (c) Tamura, Y.; Sasho, M.; Akai, S.; Kishimoto, H.; Sekihachi, J.; Kita, Y. Tetrahedron Lett. 1986, 27, 195-198;
31. (d) Kamal, A.; Bhatty, I. A.; Butt, M. A. Pak. J. Sci. Res. 1963, 15, 132-137;
32. (e) De Silva, S. O.; Reed, J. N.; Snieckus, V. Tetrahedron Lett. 1978, 19, 5099-5102;
33. (f) Schöpf, C.; Jäckh-Tettweiler, I.; Mayer, G.; Perrey-Fehrenbach, H.; Winterhalder, L. Justus Liebigs Ann. Chem. 1940, 544, 77-100.
34. Wu, G.; Guo, H.-F.; Gao, K.; Liu, Y.-N.; Bastow, K. F.; Morris-Natschke, S. L.; Lee, K.-H.; Xie, L. Bioorg. Med. Chem. Lett. 2008, 18, 5272-5276.
35. Weinstock, J.; Ladd, D. L.; Wilson, J.W.; Brush, C. K.; Yim, N. C.; Gallagher, G., Jr.; McCarthy, M. E.; Silvestri, J.; Sarau, H. M.; Flaim, K. E., et al. J. Med. Chem. 1986, 29, 2315-2325.
36. The dr under the optimized condition varied somewhat between experiments but was consistently >23:1.
37. Evdokimova, G.; Zinovyev, S.; Perosa, A.; Tundo, P. Appl. Catal., A 2004, 271, 129-136.
38. Kametani, T.; Inoue, H.; Honda, T.; Sugahara, T.; Fukumoto, K. J. Chem. Soc., Perkin Trans. 1 1977, 4, 374-376.